Triomics & Memorial Sloan Kettering Enhance Trials with AI, Google Joins b.well for Health Solutions - Life AI Weekly #40

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in Healthcare & Life Sciences AI. This week, we explore a range of collaborations and innovations that are shaping the future of healthcare. Triomics has teamed up with Memorial Sloan Kettering to enhance clinical trials using AI, while Harbour BioMed has introduced a new AI model aimed at biologics discovery. These partnerships highlight the growing role of AI in accelerating drug discovery and improving patient outcomes.

In other news, BD has launched an AI-enabled connected care platform, aiming to streamline healthcare delivery and improve patient care. Meanwhile, Google and b.well Connected Health have joined forces to develop AI health solutions, showcasing the tech giant's continued investment in healthcare innovation. Stay tuned as we continue to bring you the latest updates from the intersection of AI and healthcare.

VitVio has secured $8 million in seed funding to enhance its AI platform for improving operating room efficiency in U.S. hospitals. Meanwhile, OpenAI, along with Founders Fund and Lux Capital, has invested $30 million in Valthos, a biosecurity startup focused on AI solutions for detecting and countering biological threats.

ChemDiv has extended its partnership with Mondego Bio to advance a PTPN2-targeted immuno-oncology program, following Mondego Bio's Series A financing. Meanwhile, Triomics has teamed up with Memorial Sloan Kettering Cancer Center to leverage AI for improving clinical trial screening and expanding decentralized trials.

BiomEdit, in collaboration with Bioversity International USA and Yale University, has secured nearly $2 million from the Bezos Earth Fund to create an AI model for reducing methane emissions in cattle. Meanwhile, the Chan Zuckerberg Initiative and NVIDIA have expanded their partnership to advance life science research through the development of virtual cell models.

BGI-Research and Zhejiang Lab launched 'Genos', a genomic AI model at the ICG-20 conference in Hangzhou, designed for clinical and personalized medicine. Chromatin Bioscience and Purespring Therapeutics announced a collaboration to enhance gene therapy for kidney diseases. MGI Tech Co., Ltd. partnered with Eva Holding Group to improve access to genomic technologies in Brazil. At the 2025 Festival of Biologics in Basel, Beijing Tsingke Biotech Co., Ltd. showcased AI-driven biomanufacturing solutions. Swiss Rockets AG and Squirro AG formed a strategic partnership to enhance AI transformation in biotechnology.

YorLabs has received FDA 510(k) clearance for its Intracardiac Imaging System, enhancing cath lab efficiency with high-resolution imaging. Meanwhile, MindHYVE.ai and PIHS have partnered to integrate AI into education and healthcare in Pakistan, introducing ArthurAI™ and ChironAI™.